ELEVATE-HFpEF Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 700 participants.

Also called NCT06678841

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 700 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06678841
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Hong Kong SAR China, Japan, Malaysia, Norway, Slovenia, Switzerland, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06678841. Randomized; double masking; primary purpose treatment. Start 2025-07-09 (actual); primary completion 2028-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ELEVATE-HFpEF Clinical Study
Acronym
ELEVATE-HFpEF
Intervention (Device)
Personalized cardiac pacing
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct06678841
Content hash
6e61466e9c549eedeb90f2d847b638f51e2aeea07039b1b8f0f8f51a05afeb7a